August 7, 2026
Lympid has reached an important regulatory milestone in the development of its European tokenization infrastructure.
Lympid Labs Lda has been notified to the German Federal Financial Supervisory Authority, BaFin, as a tied agent of BMCP GmbH and is now entered in the BaFin Register of tied agents under registration number 80181928.
The registration strengthens Lympid's ability to support the structuring and distribution of tokenized financial instruments within an established European regulatory framework.
For companies looking to issue tokenized securities, bonds, structured products or other investment products, this represents an important addition to Lympid's existing technology infrastructure.
Lympid Labs Lda is a Portuguese private limited company responsible for developing and operating the Lympid white-label tokenization platform and related B2B technology solutions.
Under its tied agent arrangement, Lympid Labs Lda acts as a contractually bound broker within the meaning of Section 3(2) of the German Securities Institutions Act, or WpIG.
When carrying out investment services within this mandate, Lympid acts exclusively on behalf of and under the liability of a registered MiFID entity, a securities institution based in Munich and supervised by BaFin.
This structure allows regulated investment services associated with eligible financial instruments to be provided through the MiFID principal regulatory framework, subject to the applicable product, investor, jurisdiction and regulatory requirements.
Tokenization technology can make the issuance and administration of financial instruments considerably more efficient.
However, putting a financial instrument on a blockchain does not remove the regulatory requirements attached to that instrument.
A tokenized bond remains a bond. A tokenized security remains a security.
Depending on the structure, services such as placement, distribution, investor onboarding and the receipt and transmission of orders may fall within the European investment-services regulatory framework.
This is why Lympid has been building its infrastructure around both technology and regulated financial-market participants.
The tied agent registration brings these two layers closer together.
Instead of providing companies with tokenization software alone, Lympid can support projects through an infrastructure designed around the complete lifecycle of a tokenized financial product.
Lympid's white-label platform is designed for companies, asset managers, issuers and financial institutions that want to bring investment products on-chain without having to build the underlying infrastructure from scratch.
Depending on the specific project and regulatory structure, this can include:
The objective is to provide issuers with a single infrastructure layer from which they can manage much of the operational complexity behind launching and administering tokenized investment products.
The infrastructure can be applied to a wide range of underlying assets and financial structures.
Potential use cases include tokenized:
Bonds and debt instruments
Companies can structure debt financing and issue digital securities representing investment exposure to those instruments.
Real estate investments
Real estate assets or projects can be incorporated into financial structures that provide investors with economic exposure through tokenized instruments.
Private market investments
Private companies, funds and investment vehicles can use tokenization infrastructure to digitize investment and ownership-related workflows.
Alternative assets
Collectibles, luxury assets, commodities, intellectual property and other alternative assets can potentially form the underlying or reference asset of appropriately structured financial instruments.
Structured investment products
Tokenization can also support more sophisticated securities where investor returns depend on the performance, revenues or economics of specified underlying assets or strategies.
The exact regulatory treatment of every project depends on its legal structure, the characteristics of the instrument, the investors being targeted and the jurisdictions in which it is offered.
Europe is moving from early experiments with tokenized assets toward regulated financial-market infrastructure.
For tokenization to achieve meaningful institutional adoption, issuing a token is only one part of the equation.
Companies need infrastructure capable of combining blockchain technology with securities regulation, investor protection, compliance, payments, custody and operational administration.
That is the market Lympid is building for.
The registration of Lympid Labs as a tied agent represents another step in the evolution of Lympid from a tokenization technology provider into a broader infrastructure layer for companies launching investment products in Europe.
Lympid Labs Lda is a private limited company incorporated under the laws of the Republic of Portugal under registration number 517579499, with registered address at Avenida da Liberdade, no. 706, 2nd floor, 4710-249 Braga, Portugal.
Lympid Labs Lda is responsible for developing and operating the Lympid white-label tokenization platform and related B2B technology solutions.
Lympid Labs Lda has been notified to the German Federal Financial Supervisory Authority, BaFin, as a MiFID tied agent and is entered in the BaFin Register of tied agents under registration number 80181928.
Lympid Labs Lda is a contractually bound broker within the meaning of Section 3(2) of the German Securities Institutions Act, WpIG, and acts exclusively on behalf of and under the liability of the securities institution in Munich, when providing investment services within the applicable tied agent mandate.
The official BaFin Register of tied agents can be consulted at:
https://portal.mvp.bafin.de/database/VGVInfo
https://portal.mvp.bafin.de/database/VGVInfo/vermittler.do?cmd=unternehmenZuVermittlerAction&id=-160363856
For businesses considering tokenization, the challenge is no longer simply putting an asset on a blockchain.
The real challenge is connecting financial structuring, regulation, investor onboarding and blockchain infrastructure into a product that can actually be brought to market.
Lympid provides a white-label tokenization infrastructure designed to help businesses build and launch tokenized investment products within the European financial ecosystem.
If you are considering launching a tokenized investment product, speak with Lympid.
Book a call with us today and get a free assessment.
